DOCSLIB.ORG

Early Expression of Glycophorin C During Normal and Leukemic Human Erythroid Differentiation1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Early Expression of Glycophorin C During Normal and Leukemic Human Erythroid Differentiation1 (CANCER RESEARCH 49. 2626-2632, May 15, 1989] Early Expression of Glycophorin C during Normal and Leukemic Human Erythroid Differentiation1 Jean-Luc Villeval, Caroline Le Van Kim, Ali Bettaieb, Najet Debili, Yves Colin, Bouchra El Maliki, Dominique Blanchard, William Vainchenker,2 and Jean-Pierre Cartron Unite Inserm U 91, Hôpital Henri Mondar, 94010 Créíeil[J-L.K, A. B., N. D., W. V.], and UnitéInserm U 76, Institut National de Transfusion Sanguine, 6 rue Alexandre Cabanel, 75015 Paris [C. L. V. K., Y. C., B. E. M., D. B., J-P. C.J, France ABSTRACT red cell membrane. They carry the MN and Ss blood group antigens, respectively, and have extensive structural homolo- Glycophorins C and D (GPC and GPD) are two erythrocyte glycopro- teins which originate from the same gene but differ in their NHj-terminal gies, suggesting that they have derived by duplication of a common ancestral gene. GPC and GPD are minor components residues. The cell surface expression of these glycoproteins during normal and erythroid differentiation has been investigated with monoclonal and of the red cell membrane carrying the blood group Gerbich polyclonal antibodies and has been compared to the expression of gly- determinants. Several lines of evidence indicate that these GPs cophorin A (GPA), the major sialoglycoprotein of human red cells. Using play a critical role in regulating membrane deformability and glycosylation-independent antibodies (monoclonal or polyclonal), GPC or mechanical stability of red cells (2) by interacting via protein GPD was detected in erythroid and nonerythroid cell lineages. However, 4.1 with the membrane skeleton (3). Recently, it was suggested a glycosylation-dependent monoclonal antibody (MR4-130) detected an that GPC and GPD are encoded by the same gene (4) and that epitope on GPC which appears to be erythroid specific, suggesting that GPD might be a shortened form of GPC (5). Indeed, these two lineage specificity of this glycoprotein is related to some carbohydrate GPs differ in their NH2-terminal region (4) but are immunolog structures. During normal erythroid differentiation, GPC was expressed ically (6) and structurally (5) indistinguishable in their COOH- early at the level of erythroid progenitors (part of erythroid burst-forming unit and erythroid colony-forming unit) as detected with a glycosylation- terminal domain. independent monoclonal antibody (APO 3), whereas GPA is only present Since the red cell membrane glycophorins are now well during terminal erythroid differentiation. The MR4-130 epitope was not characterized, they represent useful markers to follow the se coordinately expressed on the cell surface with the GPC molecule in the quential steps of erythroid differentiation, and GPA has been erythroid differentiation, since it was detected at the level of the more already used for this purpose (7). GPA is synthesized during mature erythroid colony-forming unit slightly later than the GPC poly- terminal erythroid differentiation but is detected slightly earlier peptide. with PoAbs which recognize peptidic epitopes than with MoAbs In four erythroleukemic patients, blast cells blocked at discrete stages which react with carbohydrate-dependent determinants (8). of the erythroid differentiation were also investigated with antibodies and However, even with a PoAb, GPA is not detected on the surface complementary DNA probes for GPA and GPC. GPA was immunologi- of BFU-E and CFU-E (9). Only preliminary data, however, cally detected in three of four cases, and its cell surface expression was have been obtained concerning the expression of GPC during correlated with the amount of specific mRNA in the cells, as seen by Northern blot analysis. GPC was immunologically detected on the blast normal (10) and leukemic differentiation (11). In the present cells of all four patients. However, in two cases including one with positive study, we have compared the expression of GPA and GPC expression of GPA, the MR4-130 epitope was absent from the GPC during normal and leukemic erythroid differentiation using molecule. By Northern blot analysis, we found that the GPC/GPD mRNA specific antibodies, and we have investigated their biosynthesis was present at a high level in all four patient samples. Western blot by Northern blot analysis of their mRNA in four patients analysis of GPC and GPD in two of these patients revealed that these suffering from erythroleukemia. mRNAs were mostly translated into the GPD molecule, suggesting that these glycoproteins might be differently processed in certain cases of erythroleukemia. MATERIALS AND METHODS Samples. Normal bone marrow and blood samples obtained from INTRODUCTION normal donors after informed consent were collected on heparin. In Human erythrocytes carry at least four main species of sial- addition, the blast cells from 4 patients presenting an early erythroid oglycoproteins known as GPA,3 GPB, GPC, and GPD, which leukemia were analyzed; 3 of these 4 cases have been previously de scribed (11). have been extensively investigated and have been used as models Isolation of the Cells. Cells from blood and normal marrows were of integral membrane proteins (for review, see Ref. l). These separated by a Ficoll-metrizoate gradient centrifugation (Lymphoprep; GPs have a high content in sialic acid which contributes to the Nyegaard, Norway). Adherent and nonadherent cells were separated by negative charge of red cells. Moreover, they carry blood group a 2-h incubation. T-cells were separated from other mononuclear cells determinants and receptors for viruses, bacteria, and parasites. by rosette formation with 2-amino-ethylisothiouronium bromide- GPA and GPB are major and well-known constituents of the treated sheep red blood cells (12). Granulocytes were isolated by sedi mentation on dextran followed by a Ficoll-metrizoate gradient centrif Received 10/17/88; revised 1/27/89; accepted 2/9/89. ugation. The remaining red cells in the granulocyte cell pellet were The costs of publication of this article were defrayed in part by the payment removed by lysis with ammonium chloride (13). Platelets were obtained of page charges. This article must therefore be hereby marked advertisement in from platelet-rich plasma. accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ' This work was partly supported by grants from la Ligue Nationale sur le Antibodies. The antiserum directed against GPC and GPD (L 857) Cancer, from ARC (Association pour la Recherche sur le Cancer) and from the was produced by immunization of rabbits with purified GPD.4 Mono GEFLUG. clonal antibodies anti-GPC, MR4-130, and APO 3 were obtained from 2To whom requests for reprints should be addressed. 3The abbreviations used are: GPA. glycophorin A; GPB, glycophorin B; GPC, P. Rouger (14) and W. Dahr (15), respectively. Two previously de glycophorin C; GPD, glycophorin D; GP, glycoprotein; MoAb. monoclonal scribed antibodies against GPA, a murine MoAb (LICR-LON-R18) antibody; PoAb, polyclonal antibody; CA 1, carbonic anhydrase 1; BFU-E, erythroid burst-forming unit: CFU-E, erythroid colony-forming unit; CFU-GM, 4 B. El Maliki, D. Blanchard, W. Dahr, K. Beyreuther, and J-P. Carton. granulocyte-macrophage colony-forming unit; CFU-MK, megakaryocyte colony- Structural homology between the glycophorins C and D of the human erythrocyte forming unit. membrane, submitted for publication. 2626 Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 1989 American Association for Cancer Research. EXPRESSION OF GLYCOPHORIN C DURING ERYTHROID DIFFERENTIATION (16,17) and a rabbit PoAb ( 18) (generous gifts of Dr. P. A. W. Edwards tion. The monoclonal antibody APO 3 reacted with a trypsin- and Dr. C. G. Gahmberg, respectively), have also been used. A murine sensitive but neuraminidase-resistant determinant located in MoAb against myeloid cells (80H5) (19) and several rabbit PoAbs the NH2-terminal region of GPC (15). Western blot studies against myeloperoxidase (20). CA 1 (21), hemoglobin (22), and von carried out with red cell membrane preparations further indi Willebrand factor (Dakopatts. Copenhagen, Denmark) have been used cated that APO 3 reacted with GPC but not with GPD (Fig. in double staining experiments. 1). It may be deduced from these data that MR4-130 and APO Fluorescent Labeling. Indirect immunofluorescence for murine 3 are both directed against GPC without cross-reactivity for MoAbs was performed on unfixed cells with an appropriate dilution of the antibody (1/50 to 1/500 depending upon the antibody). Binding GPD. However, the MR4-130 epitope was glycosylation de was revealed by incubation with a goat anti-mouse IgG Fab'2 fragment pendent, whereas the APO 3 epitope was not. The rabbit conjugated to fluorescein 500-fold diluted (Bioart, Meudon, France). antibody L 857 was obtained by immunization with a purified Cells were either spread on a slide and examined with a Zeiss micro GPD preparation.4 The immune serum was absorbed on intact scope (Oberkochen, Federal Republic of Germany) equipped with flu erythrocytes in order to select glycosylation-independent anti orescence epiillumination or analyzed by flow cytometry. Rabbit anti- bodies directed against the intracellular or intramembranous serum against either GPA or GPC was applied on cytospinned cells after 1-min fixation by methanol; their binding was revealed by a goat domain of the minor glycophorins. As expected, the absorbed anti-rabbit IgG Fab'2 fragment conjugated to rhodamine (Cappel, Coch- antibody reacted with both GPC and GPD in Western blot analysis
Load more

Recommended publications
  • Duffy, and Mnss Group Systems
    Blood Groups – Duffy, and MNSs Group Systems Qun Lu, MD Assistant Professor Division of Transfusion Medicine Department of Pathology and Laboratory Medicine UCLA, School of Medicine Los Angeles, California 2009-03-12 Duffy Blood Group System History . 1950: Mrs. Duffy, a multiply transfused hemophiliac woman, developed an antibody not reacting with the known RBC antigens. Corresponding antigen was named after Mrs. Duffy . 1951: Fyb antibody was described in a woman with 3 pregnancies. 1955: Majority of blacks tested Fy(a-b-) . 1975: Fy(a-b-) RBCs were shown to resist infection by malaria organism Plasmodium vivax. Later: more Duffy antigens (Fy3, Fy4, Fy5, Fy6) were discovered . ISBT: 008 for the Duffy Blood Group Duffy Antigens . Most common: Fya and Fyb. Present at 6 weeks of gestation, well developed at birth – anti- Fy can cause hemolytic disease of newborn . Duffy antigens can be destroyed by enzymes such as ficin, papain, bromelain, chymotrypsin, ZZAP . When compared to Rh or Kell antigens, Duffy antigens are not very immunogenic. So, anti-Fya or anti-Fyb is not common. Fy (a-b-) is not Fy null, but homozygous for Fyb gene, they express Fyb antigen in other tissues, but not on RBCs → only will produce anti-Fya, not anti-Fyb. Fy (a-b-) is negative for Fy6 antigen which is the receptor for P. vivax (Fy6 is + when Fya + or Fyb+) Duffy Antigens . Phenotype Frequencies Chinese Phenotype Whites % Blacks % % Fy (a+b-) 17 9 90.8 Fy (a+b+) 49 1 8.9 Fy (a-b+) 34 22 0.3 Fy (a-b-) rare 68 0 White donor population: Fya: 66% Caucasians, 10% Blacks, 99% Asians Fya – units: 35% Fyb: 83% Caucasians, 23% Blacks, 18.5% Asians Fyb – units: 15% Fy3: 100% Caucasians, 32% Blacks, 99.9% Asians Duffy Antigens .
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • The Gerbich Blood Group System: a Review
    Review The Gerbich blood group system: a review P.S. Walker and M.E. Reid Antigens in the Gerbich blood group system are expressed on glycoproteins are also known as CD236R, and they attach glycophorin C (GPC) and glycophorin D (GPD), which are both to the RBC membrane through an interaction with protein encoded by a single gene, GYPC. The GYPC gene is located on 4.1R and p55. GPC and GPD contain three domains: an ex- the long arm of chromosome 2, and Gerbich antigens are in- tracellular NH2 domain, a transmembrane domain, and an herited as autosomal dominant traits. There are 11 antigens in intracellular or cytoplasmic COOH domain (Figure 1). GPC the Gerbich blood group system, six of high prevalence (Ge2, Ge3, Ge4, GEPL [Ge10*], GEAT [Ge11*], GETI [Ge12*]) and and GPD are encoded by the same gene, GYPC. When the five of low prevalence (Wb [Ge5], Lsa [Ge6], Ana [Ge7], Dha fi rst AUG initiation codon is used, GPC is encoded, whereas [Ge8], GEIS [Ge9]). GPC and GPD interact with protein 4.1R, when the second AUG is used, GPD is encoded. Thus, GPD contributing stability to the RBC membrane. Reduced lev- is a shorter version of GPC, and the amino acids in GPD els of GPC and GPD are associated with hereditary elliptocy- are identical to those found in GPC but lacking the fi rst 21 tosis, and Gerbich antigens act as receptors for the malarial amino acids at the N-terminal of GPC.9,10 parasite Plasmodium falciparum. Anti-Ge2 and anti-Ge3 have caused hemolytic transfusion reactions, and anti-Ge3 has pro- duced hemolytic disease of the fetus and newborn (HDFN).
    [Show full text]
  • How Does Protein Zero Assemble Compact Myelin?
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 13 May 2020 doi:10.20944/preprints202005.0222.v1 Peer-reviewed version available at Cells 2020, 9, 1832; doi:10.3390/cells9081832 Perspective How Does Protein Zero Assemble Compact Myelin? Arne Raasakka 1,* and Petri Kursula 1,2 1 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, NO-5009 Bergen, Norway 2 Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Aapistie 7A, FI-90220 Oulu, Finland; [email protected] * Correspondence: [email protected] Abstract: Myelin protein zero (P0), a type I transmembrane protein, is the most abundant protein in peripheral nervous system (PNS) myelin – the lipid-rich, periodic structure that concentrically encloses long axonal segments. Schwann cells, the myelinating glia of the PNS, express P0 throughout their development until the formation of mature myelin. In the intramyelinic compartment, the immunoglobulin-like domain of P0 bridges apposing membranes together via homophilic adhesion, forming a dense, macroscopic ultrastructure known as the intraperiod line. The C-terminal tail of P0 adheres apposing membranes together in the narrow cytoplasmic compartment of compact myelin, much like myelin basic protein (MBP). In mouse models, the absence of P0, unlike that of MBP or P2, severely disturbs the formation of myelin. Therefore, P0 is the executive molecule of PNS myelin maturation. How and when is P0 trafficked and modified to enable myelin compaction, and how disease mutations that give rise to incurable peripheral neuropathies alter the function of P0, are currently open questions. The potential mechanisms of P0 function in myelination are discussed, providing a foundation for the understanding of mature myelin development and how it derails in peripheral neuropathies.
    [Show full text]
  • B Cell Checkpoints in Autoimmune Rheumatic Diseases
    REVIEWS B cell checkpoints in autoimmune rheumatic diseases Samuel J. S. Rubin1,2,3, Michelle S. Bloom1,2,3 and William H. Robinson1,2,3* Abstract | B cells have important functions in the pathogenesis of autoimmune diseases, including autoimmune rheumatic diseases. In addition to producing autoantibodies, B cells contribute to autoimmunity by serving as professional antigen- presenting cells (APCs), producing cytokines, and through additional mechanisms. B cell activation and effector functions are regulated by immune checkpoints, including both activating and inhibitory checkpoint receptors that contribute to the regulation of B cell tolerance, activation, antigen presentation, T cell help, class switching, antibody production and cytokine production. The various activating checkpoint receptors include B cell activating receptors that engage with cognate receptors on T cells or other cells, as well as Toll-like receptors that can provide dual stimulation to B cells via co- engagement with the B cell receptor. Furthermore, various inhibitory checkpoint receptors, including B cell inhibitory receptors, have important functions in regulating B cell development, activation and effector functions. Therapeutically targeting B cell checkpoints represents a promising strategy for the treatment of a variety of autoimmune rheumatic diseases. Antibody- dependent B cells are multifunctional lymphocytes that contribute that serve as precursors to and thereby give rise to acti- cell- mediated cytotoxicity to the pathogenesis of autoimmune diseases
    [Show full text]
  • Flow Reagents Single Color Antibodies CD Chart
    CD CHART CD N° Alternative Name CD N° Alternative Name CD N° Alternative Name Beckman Coulter Clone Beckman Coulter Clone Beckman Coulter Clone T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells T Cells B Cells Granulocytes NK Cells Macrophages/Monocytes Platelets Erythrocytes Stem Cells Dendritic Cells Endothelial Cells Epithelial Cells CD1a T6, R4, HTA1 Act p n n p n n S l CD99 MIC2 gene product, E2 p p p CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n CD1b R1 Act p n n p n n S CD99R restricted CD99 p p CD224 GGT (γ-glutamyl transferase) p p p p p p CD1c R7, M241 Act S n n p n n S l CD100 SEMA4D (semaphorin 4D) p Low p p p n n CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p CD1d R3 Act S n n Low n n S Intest CD101 V7, P126 Act n p n p n n p CD226 DNAM-1, PTA-1 Act n Act Act Act n p n CD1e R2 n n n n S CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n l CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n l CD228 Melanotransferrin (MT), p97 p p CD3 T3, CD3 complex p n n n n n n n n n l CD104 integrin b4 chain; TSP-1180 n n n n n n n p p CD229 Ly9, T-lymphocyte surface antigen p p n p n
    [Show full text]
  • Quantitation of the Number of Molecules of Glycophorins C and D on Normal Red Blood Cells Using Radioiodinatedfab Fragments of Monoclonal Antibodies
    Quantitation of the Number of Molecules of Glycophorins C and D on Normal Red Blood Cells Using RadioiodinatedFab Fragments of Monoclonal Antibodies By Jon Smythe, Brigitte Gardner, andDavid J. Anstee Two rat monoclonal antibodies (BRAC 1 and BRAC 1 1 ) cytes. Fabfragments of BRAC 1 1 and ERIC 10 gave values have been produced. BRAC 1 recognizes an epitope com- of 143,000 molecules GPC per red blood cell (RBC). Fab mon to the human erythrocyte membrane glycoproteins fragments of BRAC1 gave 225,000 molecules of GPC and glycophorin C (GPC) and glycophorin D (GPD). BRAC 11 GPD per RBC. These results indicate that GPC and GPD is specific for GPC. Fabfragments of these antibodies and together are sufficiently abundantto provide membrane at- BRlC 10, a murine monoclonal anti-GPC,were radioiodin- tachment sites for all ofthe protein 4.1 in normal RBCs. ated and used in quantitative binding assays to measure 0 1994 by The American Societyof Hematology. the number of GPC and GPD molecules on normal erythro- HE SHAPE AND deformability of the mature human (200,000)" and those reported for GPC (50,000).7 This nu- Downloaded from http://ashpublications.org/blood/article-pdf/83/6/1668/612763/1668.pdf by guest on 24 September 2021 T erythrocyte is controlled by a flexible two-dimensional merical differencehas led to the suggestion that a significant lattice of proteins, which together comprise the membrane proportion of protein 4.1 in normal erythrocyte membranes skeleton.' The major components of the skeleton are spec- must be bound to sites other than GPC and GPD.3 The trin, actin, ankyrin, and protein 4.1.
    [Show full text]
  • Anti-Glycophorin C Antibody (ARG41471)
    Product datasheet [email protected] ARG41471 Package: 100 μl anti-Glycophorin C antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes Glycophorin C Tested Reactivity Hu Tested Application FACS, ICC/IF, IHC-P, IP, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name Glycophorin C Antigen Species Human Immunogen Synthetic peptide of Human Glycophorin C. Conjugation Un-conjugated Alternate Names Glycophorin-D; CD236R; GPD; Glycophorin-C; Glycoprotein beta; Glycoconnectin; GPC; PAS-2; CD antigen CD236; GE; CD236; Sialoglycoprotein D; GYPD; PAS-2' Application Instructions Application table Application Dilution FACS 1:50 ICC/IF 1:50 - 1:200 IHC-P 1:50 - 1:200 IP 1:50 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control K562 Calculated Mw 14 kDa Observed Size ~ 39 kDa Properties Form Liquid Purification Affinity purified. Buffer PBS (pH 7.4), 150 mM NaCl, 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide www.arigobio.com 1/2 Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol GYPC Gene Full Name glycophorin C (Gerbich blood group) Background Glycophorin C (GYPC) is an integral membrane glycoprotein.
    [Show full text]
  • Proteins That Interact with the Mucin-Type Glycoprotein Msb2p
    bioRxiv preprint doi: https://doi.org/10.1101/786475; this version posted September 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Msb2p Interacting Proteins Prabhakar et al. Proteins That Interact with the Mucin-Type Glycoprotein Msb2p Include Regulators of the Actin Cytoskeleton by Aditi Prabhakar, Nadia Vadaie, Thomas Krzystek, and Paul J. Cullen† Department of Biological Sciences at SUNY-Buffalo, 14260-1300 Running title: Msb2p interacting proteins Key Words: protein microarray, mucin, MAP kinase, actin cytoskeleton, Msb2p, actin capping, secretion, glutamine synthetase. † Corresponding author: Paul J. Cullen Address: Department of Biological Sciences 532 Cooke Hall State University of New York at Buffalo Buffalo, NY 14260-1300 Phone: (716)-645-4923 FAX: (716)-645-2975 e-mail: [email protected] 36 pages, 8 Figures, 3 Tables, , 1 Supplemental Table; 50,465 characters 1 bioRxiv preprint doi: https://doi.org/10.1101/786475; this version posted September 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Msb2p Interacting Proteins Prabhakar et al. ABSTRACT Transmembrane mucin-type glycoproteins can regulate signal transduction pathways. In yeast, signaling mucins regulate mitogen-activated protein kinase (MAPK) pathways that induce cell differentiation to filamentous growth (fMAPK pathway) and the response to osmotic stress (HOG pathway). To explore regulatory aspects of signaling mucin function, protein microarrays were used to identify proteins that interact with the cytoplasmic domain of the mucin-like glycoprotein, Msb2p.
    [Show full text]
  • Characterization of a Novel Peripheral Nervous System Myelin
    Characterization ofa Novel Peripheral Nervous System Myelin Protein (PMP22/SR13) G. Jackson Snipes,** Ueli Suter, * Andrew A. Welcher, * and Eric M. Shooter* *Department ofNeurobiology and f Department of Pathology (Neuropathology), Stanford University School of Medicine, Stanford, CA 94305 Abstract. We have recently described a novel cDNA, protein could be detected by either immunoblot analysis SR13 (Welcher, A . A., U. Suter, M . De Leon, G. J. or by immunohistochemistry. Northern and immunoblot Snipes, and E. M. Shooter. 1991. Proc. Natl. Acad. analysis of SRI 3 mRNA and protein expression during Sci. USA. 88 .7195-7199), that is repressed after sciatic development of the peripheral nervous system reveal a nerve crush injury and shows homology to both the pattern similar to other myelin proteins. Furthermore, growth arrest-specific mRNA, gas3 (Manfioletti, G., we demonstrate by in situ mRNA hybridization on tis- M. E. Ruaro, G. Del Sal, L. Philipson, and sue sections and on individual nerve fibers that SR13 C. Schneider. 1990. Mol. Cell Biol. 10:2924-2930), mRNA is produced predominantly by Schwann cells. and to the myelin protein, PASII (Kitamura, K., M. We conclude that the SR13 protein is apparently exclu- Suzuki, and K. Uyemura. 1976. Biochim. Biophys. sively expressed in the peripheral nervous system Acta. 455 :806-816). In this report, we show that the where it is a major component of myelin. Thus, we 22-kD SR13 protein is expressed in the compact portion propose the name Peripheral Myelin Protein-22 (PMP- of essentially all myelinated fibers in the peripheral 22) for the proteins and cDNAs previously designated nervous system.
    [Show full text]
  • Blood Group Antigens As Receptors for Bacteria and Parasites
    Review: blood group antigens as receptors for bacteria and parasites C. LOMAS-FRANCIS Abbreviations: Gal = galactose; Glc = glucose; NeuAc lectins.4 Lectins are a class of proteins of nonimmune = N-acetylneuraminic acid; GlcNAc = N-acetylglu- origin that can combine with sugars rapidly, selective- cosamine; GalNAc = N-acetylgalactosamine; FUC = ly, and, since binding is noncovalent, reversibly. Lectins fucose; Cer = ceramide. are not confined to plants but are widespread through- out nature, and frequently appear on surfaces of cells, An important phase in the initiation of diseases caused where they are strategically positioned to combine by bacterid and parasites is the adhesion of the infectious with complementary sugars on neighboring cells. agent to tissues of the mammalian host. Adhesion is Lectins are exquisitely specific; they can distinguish mediated by specificligand-receptor interactions. Host between different monosaccharides and specifically cell receptors include a number of structures carrying bind to oligosaccharides, detecting subtle differences blood group antigens. A selection of such receptors and in complex carbohydrate structures. the attaching microorganisms, mostly bacteria, are listed Bacterial attachment to epithelial cells and to RBCs in Table 1 and will be reviewed in this article. results from the interaction of host cell receptors with bacterial surface structures known as fimbriae or pili.5 Table 1. Receptors for bacteria and parasites These submicroscopic hair-like appendages are 5 to 10 Receptors Bacteria and parasites nanometers in diameter and several hundreds of Ii Mycoplasmapneumuniae nanometers long. They protrude from the surface of P1, P, andPk P-fimbriated Escherichia coli the bacteria and serve as bacterial-binding factors by AnWj Haemophilus influenzae producing lectin-like adhesins or hemagglutinins.
    [Show full text]